-
Published 9/16/2025
Urae S, Wang Z, Kumar S, Chen HA, Henderson JM, Beck LH, Borkan SC. Nucleophosmin (NPM) Promotes Regulated Cell Death in Podocyte Injury. Kidney360. 2025 Sep 16. PMID: 40956614.
-
Published 7/29/2025
Wittig M, Verma A, Bellavia A, Rosan S, Claudel SE, Surapaneni A, Palsson R, Srivastava A, Stillman IE, Henderson JM, Beck LH, Hodgin JB, Grams ME, Rhee EP, Huber TB, Waikar SS, Schmidt IM. The Associations of Foot Process Effacement with Kidney Histopathologic Lesions and Disease Progression. Kidney360. 2025 Jul 29. PMID: 40728890.
-
Published 3/28/2025
Laudon A, Wang Z, Zou A, Sharma R, Ji J, Tan W, Kim C, Qian Y, Ye Q, Chen H, Henderson JM, Zhang C, Kolachalama VB, Lu W. Digital pathology assessment of kidney glomerular filtration barrier ultrastructure in an animal model of podocytopathy. Biol Methods Protoc. 2025; 10(1):bpaf024. PMID: 40223818.
-
Published 3/20/2025
Demmer RT, Wu C, Kim JS, Sun Y, Balte P, Cushman M, Boyle R, Tracy RP, Styer LM, Bell TD, Anderson MR, Allen NB, Schreiner PJ, Bowler R, Schwartz DA, Lee JS, Xanthakis V, Rock JM, Bievenue R, Pirzada A, Doyle M, Regan EA, Make BJ, Kanaya AM, Kandula NR, Wenzel SE, Coresh J, Isasi CR, Raffield LM, Elkind MSV, Howard VJ, Ortega VE, Woodruff P, Cole SA, Henderson JM, Mantis NJ, Oelsner EC. Demographic and Clinical Factors Associated With SARS-CoV-2 Anti-Nucleocapsid Antibody Response Among Previously Infected US Adults: The C4R Study. Open Forum Infect Dis. 2025 Mar; 12(3):ofaf123. PMID: 40124199.
-
Published 3/20/2025
Battaglini J, Henderson J, Sanchorawala V, Szalat R. Teclistamab therapy for refractory type 1 cryoglobulinemia. Haematologica. 2025 Aug 01; 110(8):1891-1893. PMID: 40109179.